Attrv-Pn, Faith (AstraZeneca): "Eplontersen Objectives Achieved Widely During the Study"

Il Tempo

Il Quotidiano del Sud

View article

newsbiella.it

View article

+2 Reposted by 2 other sources

Right

Factuality

Ownership

Milan, 21 Sep. (Adnkronos Salute) - "The approval of eplontersen is a very important result born from the phase III study Neuro-TTRansform, which had three co-primary objectives absolutely centered and relevant in the hereditary amyloidosis of transtiretin in its form of polyneuropathy. The three objectives, widely achieved by eplontersen during the phase III study Neuro-TTRansform, bringing great benefits, were the plasma reduction of transtire…

notizie.it

Rec News | Lontani dal mainstream

View article

Reposted by

Rec News | Lontani dal mainstream

Factuality

Ownership

(Adnkronos) - “The approval of eplontersen is a very important result born from the phase III Neuro-TTransform study, which had three co-primary objectives